A case of destructive Wegener's granulomatosis complicated by cytomegalovirus infection

被引:12
作者
Aries, Peer M.
Ullrich, Sebastian
Gross, Wolfgang L.
机构
[1] Rheumaklin Bad Bramstedt, Dept Internal Med Rheumatol & Clin Immunol, D-34576 Bad Bramstedt, Germany
[2] Univ Hosp Schleswig Holstein, Dept Rheumatol, Lubeck, Germany
来源
NATURE CLINICAL PRACTICE RHEUMATOLOGY | 2006年 / 2卷 / 09期
关键词
cytomegalovirus; ear; nose and throat; esophagitis; infection; Wegener's granulomatosis;
D O I
10.1038/ncprheum0269
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background A 63-year-old man with a 4-year history of Wegener's granulomatosis presented with hemoptysis, palatal ulceration and sensorimotor polyneuropathy. Investigations Physical examination, serologic testing, proteinase 3 enzyme-linked immunosorbent assay, IgG and IgM specific to Epstein-Barr virus enzyme-linked immunosorbent assay, MRI of the middle face, an ear, nose and throat consultation, immunohistochemical staining of an esophageal sample obtained from esophagogastroduodenoscopy, polymerase chain reaction of cytomegalovirus (CMV) DNA from esophageal and blood samples, and measurement of pp65 early antigen. Diagnosis Wegener's granulomatosis with progressive palatal ulceration and osseous destruction complicated by CMV-related esophagitis during induction treatment. Management Induction treatment with cyclophosphamide pulse therapy was discontinued and antiviral therapy with ganciclovir was started. Cyclophosphamide pulse therapy was later reintroduced, but there was subsequent CMV reactivation, and, therefore, cyclophosphamide pulse therapy was suspended again and ganciclovir and intravenous immunoglobulin were started. After control of CMV, cyclophosphamide pulse therapy was reinitiated. Prolonged immunosuppressive therapy controlled disease activity, without CMV reactivation.
引用
收藏
页码:511 / 515
页数:5
相关论文
共 18 条
[1]   Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations [J].
Aries, P. M. ;
Hellmich, B. ;
Voswinkel, J. ;
Both, M. ;
Noelle, B. ;
Holl-Ulrich, K. ;
Lamprecht, P. ;
Gross, W. L. .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (07) :853-858
[2]   Intravenous immunoglobulin therapy in vasculitis - Speculation or evidence? [J].
Aries, PM ;
Hellmich, B ;
Gross, WL .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2005, 29 (03) :237-245
[3]  
BLAND R, 1992, NEW STATESMAN SOC, V5, P25
[4]   TREATMENT OF AIDS-ASSOCIATED GASTROINTESTINAL CYTOMEGALOVIRUS-INFECTION WITH FOSCARNET AND GANCICLOVIR - A RANDOMIZED COMPARISON [J].
BLANSHARD, C ;
BENHAMOU, Y ;
DOHIN, E ;
LERNESTEDT, JO ;
GAZZARD, BG ;
KATLAMA, C .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (03) :622-628
[5]   ESOPHAGEAL INVOLVEMENT IN BEHCETS-DISEASE - IS ENDOSCOPY NECESSARY [J].
BOTTOMLEY, WW ;
DAKKAK, M ;
WALTON, S ;
BENNETT, JR .
DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (04) :594-597
[6]  
de Groot K, 2005, CLIN NEPHROL, V64, P480
[7]  
Dykewicz CA, 2000, BIOL BLOOD MARROW TR, V6, P659
[8]   WEGENERS GRANULOMATOSIS - PROSPECTIVE CLINICAL AND THERAPEUTIC EXPERIENCE WITH 85 PATIENTS FOR 21 YEARS [J].
FAUCI, AS ;
HAYNES, BF ;
KATZ, P ;
WOLFF, SM .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (01) :76-85
[9]   Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials [J].
Hodson, EM ;
Jones, CA ;
Webster, AC ;
Strippoli, GF ;
Barclay, PG ;
Kable, K ;
Vimalachandra, D ;
Craig, JC .
LANCET, 2005, 365 (9477) :2105-2115
[10]  
JACOBSON MA, 2006, AIDS RELATED CYTOMEG